000 | 02658na a2200313 4500 | ||
---|---|---|---|
003 | PC69 | ||
005 | 20180417114626.0 | ||
008 | 130622s2011 xxx||||| |||| 00| 0 eng d | ||
040 |
_a _cH12O |
||
041 | _aeng | ||
100 |
_9560 _aAbradelo de Usera, Manuel _eCirugía General y Aparato Digestivo |
||
100 |
_aGómez Sanz, Ramón _91065 _eCirugía General y del Aparato Digestivo |
||
100 |
_9358 _aJiménez Romero, Carlos _eCirugía General y del Aparato Digestivo |
||
100 |
_9558 _aLoinaz Segurola, Carmelo _eCirugía General y del Aparato Digestivo |
||
100 |
_aMeneu Díaz, Juan Carlos _91087 _eCirugía General y del Aparato Digestivo |
||
100 |
_91079 _aMoreno Elola-Olaso, Almudena _eCirugía General y del Aparato Digestivo |
||
100 |
_9510 _aMoreno González, Enrique _eCirugía General y del Aparato Digestivo |
||
245 | 0 | 4 |
_aThe influence of immunosuppression switching in liver function in adult hepatic transplantation _h[artículo] |
260 |
_bHepatogastroenterology, _c2011 |
||
300 | _a58(106):532-535. | ||
337 | _aJOUR | ||
500 | _aFormato Vancouver: Marín Gómez LM, Loinaz Segurota C, Moreno González E, Moreno Elola-Olaso A, González-Pinto Arrillaga I, Meneu Díaz JC, et al. The influence of immunosuppression switching in liver function in adult hepatic transplantation. Hepatogastroenterology. 2011;58(106):532-5. | ||
501 | _aPMID: 21661426 | ||
504 | _aContiene 10 referencias | ||
520 | _aWe evaluate the 5-year results of a single-centre prospective randomized trial that compared cyclosporine microemulsion (CyA-me) in triple therapy (plus steroids and azathioprine) and Tacrolimus (Tac) in double therapy (plus steroids) for primary immunosuppression. One hundred adult patients undergoing liver transplantation were randomized to receive Tac (n=51) or CyA-me (n=49). Ten patients in group A, and thirty-one patients in group B had their main immunosuppressive agent switched. The switch was much more frequent from CyA-me to Tac (n=31; 62.3%), mainly because of lack of efficacy (n=12; 38.7%). Six of 10 patients were shifted from Tac to CyA-me for side effects. The clinical course of the majority of patients converted from CyA-me to Tac improved clearly after conversion. Donor age and acute rejection (number, severity and rejection free days) had a significative association with lack of efficacy in group B. In these series, the conversion to Tac from CyA-me could be accomplished safely, with an excellent long-term outcome. | ||
710 |
_9271 _aServicio de Cirugía General y del Aparato Digestivo |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc69.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |
||
999 |
_c69 _d69 |